Antimicrobial Synergy of Silver-Platinum Nanohybrids With Antibiotics.
antibiofilm
antimicrobial synergy
biogenic synthesis
characterization
silver-platinum nanohybrids
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2020
2020
Historique:
received:
28
09
2020
accepted:
22
12
2020
entrez:
18
2
2021
pubmed:
19
2
2021
medline:
19
2
2021
Statut:
epublish
Résumé
Various bacterial pathogens are responsible for nosocomial infections resulting in critical pathophysiological conditions, mortality, and morbidity. Most of the bacterial infections are associated with biofilm formation, which is resistant to the available antimicrobial drugs. As a result, novel bactericidal agents need to be fabricated, which can effectively combat the biofilm-associated bacterial infections. Herein, for the first time we report the antimicrobial and antibiofilm properties of silver-platinum nanohybrids (AgPtNHs), silver nanoparticles (AgNPs), and platinum nanoparticles (PtNPs) against
Identifiants
pubmed: 33597929
doi: 10.3389/fmicb.2020.610968
pmc: PMC7882503
doi:
Types de publication
Journal Article
Langues
eng
Pagination
610968Informations de copyright
Copyright © 2021 Ranpariya, Salunke, Karmakar, Babiya, Sutar, Kadoo, Kumbhakar and Ghosh.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
mBio. 2014 Jun 10;5(3):e01206-14
pubmed: 24917599
FEMS Immunol Med Microbiol. 2010 Aug;59(3):227-38
pubmed: 20412300
J Photochem Photobiol B. 2017 Jan;166:246-251
pubmed: 28011434
Antibiotics (Basel). 2020 Mar 20;9(3):
pubmed: 32244927
Crit Rev Microbiol. 2017 Nov;43(6):651-667
pubmed: 28358585
Microb Pathog. 2016 May;94:27-34
pubmed: 26416306
Wound Repair Regen. 2008 Jan-Feb;16(1):37-44
pubmed: 18086294
Pathogens. 2016 Nov 30;5(4):
pubmed: 27916925
Diabetes Metab Syndr. 2013 Apr-Jun;7(2):101-7
pubmed: 23680250
Curr Top Microbiol Immunol. 2008;322:249-89
pubmed: 18453280
Trends Biotechnol. 2016 Jul;34(7):588-599
pubmed: 26944794
Laryngoscope. 2001 Dec;111(12):2083-94
pubmed: 11802002
Int J Nanomedicine. 2012;7:483-96
pubmed: 22334779
Front Microbiol. 2016 Jan 20;6:1528
pubmed: 26834706
Pathog Dis. 2013 Apr;67(3):159-73
pubmed: 23620179
Microorganisms. 2017 Mar 07;5(1):
pubmed: 28272369
Clin Rev Allergy Immunol. 2008 Dec;35(3):124-34
pubmed: 18509765
J Wound Care. 2011 Nov;20(11):543-9
pubmed: 22240850
Pathog Dis. 2013 Feb;67(1):25-38
pubmed: 23620117
PLoS One. 2020 Jul 14;15(7):e0235892
pubmed: 32663201
Bioprocess Biosyst Eng. 2010 Jan;33(1):159-64
pubmed: 19701776
J Trace Elem Med Biol. 2020 Mar;58:126448
pubmed: 31901726
Int J Nanomedicine. 2014 May 27;9:2635-53
pubmed: 24920901
Langmuir. 2011 Apr 5;27(7):4020-8
pubmed: 21401066
Int J Nanomedicine. 2015 Dec 17;10:7477-90
pubmed: 26719690
Saudi Pharm J. 2016 Jul;24(4):473-84
pubmed: 27330378
Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S350-9
pubmed: 18462090
Arch Ophthalmol. 2008 Nov;126(11):1572-81
pubmed: 19001227
PLoS One. 2019 Nov 8;14(11):e0224904
pubmed: 31703098
Int J Bacteriol. 2013;2013:
pubmed: 25750934
ScientificWorldJournal. 2014;2014:704708
pubmed: 25093206
Prog Biomater. 2020 Sep;9(3):81-95
pubmed: 32654045
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S886-S899
pubmed: 30422688
ACS Appl Mater Interfaces. 2017 Apr 26;9(16):13837-13848
pubmed: 28383253
Front Chem. 2019 Nov 28;7:824
pubmed: 31850313